Cargando…

Microparticles as Novel Biomarkers and Therapeutic Targets in Coronary Heart Disease

Detalles Bibliográficos
Autores principales:	Zhou, Bo-Da, Guo, Ge, Zheng, Le-Min, Zu, Ling-Yun, Gao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837849/ https://www.ncbi.nlm.nih.gov/pubmed/25591573 http://dx.doi.org/10.4103/0366-6999.149231

Ejemplares similares

Endothelial Microparticles in Uremia: Biomarkers and Potential Therapeutic Targets
por: Favretto, Giane, et al.
Publicado: (2019)

The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics
por: Coleman, Leon G.
Publicado: (2021)

Validation of a particle tracking analysis method for the size determination of nano- and microparticles
por: Kestens, Vikram, et al.
Publicado: (2017)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

HDL as a Biomarker, Potential Therapeutic Target, and Therapy
por: Navab, Mohamad, et al.
Publicado: (2009)

Quantifying the Importance of Interleukin-6 for Coronary Heart Disease
por: Neal, Bruce
Publicado: (2008)

Machine learning in diagnosis of coronary artery disease
por: Ling, Hao, et al.
Publicado: (2021)

ULK1 as a novel therapeutic target in neurodegeneration
por: Vahsen, Björn Friedhelm, et al.
Publicado: (2020)

Dysfunction of axonal transport in normal-tension glaucoma: a biomarker of disease progression and a potential therapeutic target
por: Hirooka, Kazuyuki, et al.
Publicado: (2020)

Free ubiquitin: a novel therapeutic target for neurodegenerative diseases
por: Park, Chul-Woo, et al.
Publicado: (2021)

FBXO45 is a potential therapeutic target for cancer therapy
por: Lin, Min, et al.
Publicado: (2020)

Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins
por: Lv, Ping, et al.
Publicado: (2020)

Complement Activation on Endothelial Cell-Derived Microparticles—A Key Determinant for Cardiovascular Risk in Patients with Systemic Lupus Erythematosus?
por: Martin, Naomi, et al.
Publicado: (2020)

Cancer Stem Cells Therapeutic Target Database: The First Comprehensive Database for Therapeutic Targets of Cancer Stem Cells
por: Hu, Xiaoqing, et al.
Publicado: (2016)

Targeting microthrombosis and neuroinflammation with vepoloxamer for therapeutic neuroprotection after traumatic brain injury
por: Xiong, Ye, et al.
Publicado: (2018)

Chitinase 3-like-1, a novel regulator of Th1/CTL responses, as a therapeutic target for increasing anti-tumor immunity
por: Kim, Do-Hyun, et al.
Publicado: (2018)

Role of Brahma-related gene 1 (Brg1) in heart disease
por: Huang, Wen-Bo, et al.
Publicado: (2021)

Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease
por: Waghabi, Mariana Caldas, et al.
Publicado: (2022)

LIM kinases in synaptic plasticity and their potential as therapeutic targets
por: Halász, Éva, et al.
Publicado: (2020)

TREM2 as an evolving therapeutic target in Alzheimer’s disease
por: George, Jacob
Publicado: (2023)

Multifunctional glycolipids as multi-targeting therapeutics for neural regeneration
por: Itokazu, Yutaka
Publicado: (2023)

Coronary Anatomy in Congenital Heart Disease: The Important Contributions of Professor Dr. Adriana Gittenberger-de Groot
por: Hazekamp, Mark
Publicado: (2021)

Novel Therapeutic Targets in the Brain Tumor Microenvironment
por: Phillips, Joanna J.
Publicado: (2012)

Astrocytic Kir4.1 potassium channels as a novel therapeutic target for epilepsy and mood disorders
por: Ohno, Yukihiro
Publicado: (2018)

Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma
por: Liu, Qian, et al.
Publicado: (2021)

Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?
por: Baron, Morgane, et al.
Publicado: (2012)

Biomolecular Self-Defense and Futility of High-Specificity Therapeutic Targeting
por: Rosenfeld, Simon
Publicado: (2011)

Cell-specific mineralocorticoid receptors: future therapeutic targets for stroke?
por: Dinh, Quynh N., et al.
Publicado: (2016)

Gut microbiota: a potential therapeutic target for Parkinson’s disease
por: Baizabal-Carvallo, José Fidel
Publicado: (2020)

Genetics provides new individualized therapeutic targets for Parkinson’s disease
por: Garcia, Eric Joshua, et al.
Publicado: (2020)

The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses
por: Leung, Anthony K. L., et al.
Publicado: (2022)

LACTB, a Metabolic Therapeutic Target in Clinical Cancer Application
por: Li, Xiaohua, et al.
Publicado: (2022)

Spreading Senescent Cells’ Burden and Emerging Therapeutic Targets for Frailty
por: Marcozzi, Serena, et al.
Publicado: (2023)

OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
por: Wong, David C. S., et al.
Publicado: (2023)

New unexpected role for Wolfram Syndrome protein WFS1: a novel therapeutic target for Alzheimer’s disease?
por: Chen, Shuo, et al.
Publicado: (2022)

A peripheral blood transcriptome biomarker test to diagnose functional recovery potential in advanced heart failure
por: Deng, Mario C
Publicado: (2018)

Autophagy inhibition: a new therapeutic target in spinal muscular atrophy
por: Piras, Antonio, et al.
Publicado: (2018)

miR-124, a potential therapeutic target in colorectal cancer
por: Qin, Zhen, et al.
Publicado: (2019)

Neurovascular ageing: transcriptomic readout and implications on therapeutic targeting in Alzheimer's disease
por: Li, Zhongqi, et al.
Publicado: (2021)

CD34(+) progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_87j7rs0j5n3d670po1vnhpjp3u